Programme

Morning Abstract and Concurrent Sessions

LMIC health system strengthening in transplantation: Improving access sustainably in Africa

8:00 AM – 9:00 AM Room C4.4 Concurrent
Moderator / Panelist: David Thomson (ZA)
- AFRAN: Who we are and what we offer
  
  Intissar Haddiya (MA)
- Rwanda
  
  Emmanuel Muhawenimana (RW)
- Ethiopia
  
  Mekdim Tadesse Siyoum (ET)
- Panel discussion
  
  Discussion Period (AU)

LMIC Health System Strengthening in Transplantation: Improving Access Sustainably in Pacific Asia

9:10 AM – 10:15 AM Room C4.4 Concurrent
- Vitalink: Who we are and what we offer
  
  Curie Ahn (KR)
- Fiji
  
  Anis Ta'eed (FJ)
- Vietnam
  
  Thu Du (VN)
- Philippines
  
  Rose Marie Rosete-Liquete (PH)

Biogen Corporate Breakfast Symposium on Advancements in Antibody-Mediated Rejection and Microvascular Inflammation of Kidney Allograft

7:00 AM – 8:00 AM Room Parkside 1&2 Industry Symposium

Organized by

No lectures listed yet.

Basic mechanisms of experimental kidney allograft injury

8:00 AM – 9:00 AM Room Cockle Bay 1 Abstract Session
Moderator: Shane Grey (AU)
- SPP1 as a predictive biomarker and therapeutic target in fibrotic
  
  Zijie Wang (CN) · 401-1
  
  Details
- An AAV-Mediated Murine Model for the Study of ABO-Incompatible Kidney Transplantation
  
  Jiang Zhang (CN) · 401-2
  
  Details
- FCGR4+ Macrophages Promote Endothelial Cell Injury by Antibody-Dependent Cellular Phagocytosis in Antibody-Mediated Rejection after Kidney Transplantation
  
  Bin Ni (CN) · 401-3
  
  Details
- Histidine metabolism arms macrophages against chronic kidney
  
  Bin Ni (CN) · 401-4
  
  Details
- Mitochondrial injury in human and mouse kidneys with ischemia reperfusion injury
  
  Slaghaniya Neupane (CA) · 401-5
  
  Details
- METTL3 Potentiates M2 Macrophage-Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF-β1/Smad3 Pathway
  
  Dajin Chen (CN) · 401-6
  
  Details
- TLS-mediated B cell–SPP1⁺ macrophage–EndMT axis drives renal allograft fibrosis and its modulation by Iguratimod
  
  Lei Jiang (CN) · 401-9
  
  Details
- CX3CL1⁺ HEV licenses gut-imprinted CX3CR1+ myeloid cells to form an ectopic TLS niche and drive chronic renal allograft dysfunction
  
  Lei Jiang (CN) · 401-10
  
  Details
- Nintedanib significantly attenuated the progression of chronic allograft nephropathy via the inhibition of macrophage
  
  Runmin Ding (CN) · 401-11
  
  Details

Tolerance versus rejection 2

8:00 AM – 9:00 AM Room Cockle Bay 2 Abstract Session
- Histopathological and spatial transcriptomic features of immune checkpoint inhibitor-related T cell–mediated rejection after liver transplantation
  
  Wen-rui Wu (CN) · 402-1
  
  Details
- A novel depleting anti-CD2 monoclonal antibody for induction of mixed chimerism and allograft tolerance in nonhuman primates
  
  Avery Wilson (US) · 402-2
  
  Details
- Targeting the CXCL10–CXCR3 Axis Attenuates Macrophage Infiltration and Ameliorates Antibody-Mediated Rejection
  
  Tian Wei (CN) · 402-3
  
  Details
- NAMPT crotonylation dictates cardiomyocyte autophagy to modulate immune rejection in murine heart transplantation
  
  Ruidong Ding (CN) · 402-4
  
  Details
- TCF-1+ progenitor-like T cells sustain localized effector responses that mediate allograft rejection
  
  Faruk Sacirbegovic (US) · 402-5
  
  Details
- Epigenetic Erasure of Pro-inflammatory Programs by VISTA Reshapes Macrophage Fate to Mitigate Acute Cardiac Allograft Rejection
  
  Lifei Liang (CN) · 402-6
  
  Details
- LEA29Y expression executes a heterogenous protective effect on cardiac transplants in a porcine allograft model
  
  Andrea Bähr (DE) · 402-7
  
  Details

Kidney allograft rejection; mechanisms and novel therapeutics

8:00 AM – 9:00 AM Room C3.3 Abstract Session
Moderator: William Mulley (AU)
- Subthreshold Inflammation Matters: A Continuum Model of TCMR Risk
  
  Aravind Cherukuri (US) · 403-1
  
  Details
- Microvascular Inflammation(MVI) In The Crosshairs: Do Allo- or Autoantibodies Shape Kidney Allograft Pathology?
  
  Vamsee Chirumamilla (US) · 403-2
  
  Details
- Augmented washed microbiota transplantation for chronic allograft fibrosis in renal transplantation
  
  HONGDI CAO (CN) · 403-3
  
  Details
- Clinical outcomes of the use of subcutaneous daratumumab for donor-derived cell-free DNA guided treatment of antibody mediated rejection in asian kidney transplant recipients at the Singapore General Hospital
  
  Terence Kee (SG) · 403-4
  
  Details
- Upregulation of cell death pathways in kidney rejection
  
  Xinyi Ding (AU) · 403-5
  
  Details
- Kidney allograft outcomes in acute T cell-mediated rejection accompanied by microvascular inflammation: An inverse probability weighted multicentre cohort study
  
  Jiayue Wang (AU) · 403-6
  
  Details
- Molecular Diagnosis of kidney allograft rejection using the BHOT gene panel-based HistoMx System in Chinese population: a validation study
  
  Huanxi Zhang (CN) · 403-7
  
  Details

Insights into old and new therapeutics 2

8:00 AM – 9:00 AM Room C3.4-C3.5 Abstract Session
Moderator: Philip O'Connell (AU)
- Preventing post-transplant squamous cell carcinoma: Q-2361 reverses tacrolimus-induced keratinocyte transformation
  
  James Wells (AU) · 404-1
  
  Details
- Cellular Senescence Drives Age-Related Resistance to Costimulatory Blockade in Transplantation
  
  Sarah Tsou (US) · 404-2
  
  Details
- A new treatment for infants with congenital nephrotic syndrome: pre-emptive kidney transplantation along with simultaneous bilateral nephrectomy
  
  Lan Zhu (CN) · 404-3
  
  Details
- Sequential CD38 Monoclonal Antibody Induction Followed by Azathioprine Maintenance versus Continuous CD38 Therapy for Chronic Active Antibody-Mediated Rejection: A NK Cell-Targeted Comparative Study
  
  Chunchun Wei (CN) · 404-4
  
  Details
- Senolytic therapy drives immune remodeling in the aged kidney microenvironment
  
  Martin Jaros (DE) · 404-5
  
  Details
- Tacrolimus-resistant regulatory T cells in allotransplantation
  
  Naeem Abdul Ghafoor (GB) · 404-6
  
  Details
- An ROS-responsive targeted nanoplatform for precise rapamycin delivery to alleviate hepatic ischemia–Reperfusion injury
  
  Yuhang Li (CN) · 404-7
  
  Details
- Exosomal miR-106b-5p derived from MDSC repair renal transplantation ischemia-reperfusion injury via targeting PDK4
  
  Xiaoyan Huang (CN) · 404-8
  
  Details

Key components of an ideal high volume transplant program setup: A global surgical perspective

8:00 AM – 9:00 AM Room C3.6 Concurrent
Moderators: Dieter Broering (SA), Meng Qingze (CN)
- The American perspective
  
  Robert A. Montgomery (US)
- The European perspective
  
  Jiri Fronek (CZ)
- The Asian perspective
  
  Ashwin Rammohan (IN)
- The Oceania perspective
  
  Henry Pleass (AU)
- Panel discussion
  
  Discussion Period (AU)

Metabolic dysfunction and liver transplantation

8:00 AM – 9:00 AM Room C4.1 Concurrent
- Obesity, diabetes and MAFLD- A target or bystander?
  
  Dinesh Jothimani (IN)
- Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD
  
  Kymberly Watt (US)
- Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?
  
  Marina Berenguer (ES)

Immune tolerance, biomarkers, and chronic allograft injury in liver transplantation

8:00 AM – 9:00 AM Room C4.5 Abstract Session
Moderator: Nancy Kwan Man (HK)
- ANXA1 and FPR signaling promotes immune tolerance by suppressing neutrophil extracellular traps after pediatric liver transplantation
  
  Ruofan Wang (CN) · 409-1
  
  Details
- Regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in adult live donor liver transplantation
  
  Angus Thomson (US) · 409-2
  
  Details
- Liver-resident natural killer cells promote immune tolerance after liver transplantation via the PDL1/PD1 axis: Toward engineered cell therapy
  
  Haitao Huang (CN) · 409-3
  
  Details
- Tumor burden rather than incidence of acute rejection indicates 1-year OFS and RFS
  
  Jiwei Qin (CN) · 409-4
  
  Details
- Pretransplant natural killer cell activity predicts hpatocellular carcinoma recurrence and survival after living donor liver transplantation
  
  Ho Joong Choi (KR) · 409-5
  
  Details
- Integrative Transcriptomics and Machine Learning Identify Inflammatory and Profibrotic signalling as a Central Driver of Immune-Mediated Fibrosis in Chronic Liver Allograft Rejection.
  
  Marco Santillán Pazmiño (AR) · 409-6
  
  Details
- Impact of the high baseline anti-A/B antibody titer on the clinical outcomes in ABO-incompatible living donor liver transplantation
  
  Jai Young Cho (KR) · 409-7
  
  Details
- Iguratimod attenuates chronic allograft fibrosis by inhibiting macrophage–myofibroblast transformation via NCOA4-dependent ferritinophagy
  
  HONGDI CAO (CN) · 409-8
  
  Details

Ethics and kidney transplantation

8:00 AM – 9:00 AM Room C4.6 Abstract Session
Moderators: Aviva Goldberg (CA), Ruben Omar Schiavelli (AR)
- Operational guidelines for the National kidney swap transplantation program in India: A modified Delphi Consensus by Indian Society of Organ Transplantation and National Organ and Tissue Transplant Organization
  
  Pranjal Kashiv (IN) · 410-1
  
  Details
- The role of comorbidities and insurance type in explaining intersectional racial and gender disparities in kidney transplant waitlisting: A mediation analysis
  
  Annika Gompers (US) · 410-2
  
  Details
- The kidney waiting list index (KiWI): Design and validation of the aotearoa New Zealand kidney transplant waiting list score
  
  Helen L. Pilmore (NZ) · 410-3
  
  Details
- Residential Neighborhood Social Capital and Access to Live Donor Kidney Transplantation
  
  Mara McAdams DeMarco (US) · 410-4
  
  Details
- Economic evaluation of the Proposed Kidney Only Allocation Algorithm (KOALA) in Australia
  
  Yitong Yao (AU) · 410-5
  
  Details
- Ethnicity and early clinical outcomes in older adult kidney transplant recipients: insights from a multi-ethnic cohort
  
  Zhan Yi Lim (GB) · 410-6
  
  Details
- Graft outcomes following selective delisting of unacceptable HLA antigens in highly sensitised kidney transplant recipients within a multi-ethnic population
  
  Zhan Yi Lim (GB) · 410-7
  
  Details
- Ethical and cultural dimensions of deceased organ donation consent in a multinational trauma ICU: A five-year experience from the United Arab Emirates
  
  Ammar Abdelhadi (AE) · 410-8
  
  Details

Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival

8:00 AM – 9:00 AM Room C4.7 Abstract Session
Moderators: Hanne Scholz (NO), Angelika C. Gruessner (US)
- A multi-centre study of Belatacept and Sirolimus for human islet transplantation
  
  Natasha Rogers (AU) · 411-1
  
  Details
- The potential of Macaca fuscata, as a recipient model for porcine islet xenotransplantation
  
  Naoaki Sakata (JP) · 411-2
  
  Details
- Subcutaneous cell sheet transplantation as a superior strategy to intraportal route for induced pluripotent stem cell-derived pancreatic islet cells therapy
  
  Koki Kurahashi (JP) · 411-3
  
  Details
- Engineering Pancreatic Islet Organoids with a Hierarchical Vascular Network
  
  Jialin Cui (JP) · 411-4
  
  Details
- Development of a Pre-vascularized Subcutaneous Site Using a Clinically Available Bioabsorbable Device for Islet Transplantation
  
  Norio Emoto (JP) · 411-5
  
  Details
- Generation of ISL1-Overexpressing Islets with Enhanced Resistance to Apoptosis and Ferroptosis Improves Transplantation Outcomes
  
  Ying Wang (CN) · 411-6
  
  Details
- Immune cell and serum cytokine dynamics in islet transplant recipients receiving Belatacept/Sirolimus versus Tacrolimus/Mycophenolate
  
  Rachel Cheong (AU) · 411-7
  
  Details
- PTBP1 promotes autophagy via the Slc22a17/Lcn2 axis to alleviate apoptosis in grafted islets
  
  Jingwen Wang (CN) · 411-8
  
  Details
- Pharmacological Inhibition of mtROS-ARA-12-HETE Axis Enhances the Function and Therapeutic Potential of Stem Cell-Derived β Cells for Diabetes
  
  Huanjing Bi (CN) · 411-9
  
  Details

CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers

8:00 AM – 9:30 AM Room C4.8 Concurrent
Moderators: Wanessa T. Clemente (BR), Jeremy Chapman (AU)
- Pearls from the BK guidelines
  
  Nassim Kamar (FR)
- Pearls from the CMV guidelines
  
  Camille N. Kotton (US)
- Beyond the guidelines- new developments and future directions: BK
  
  Germaine Wong (AU)
- Beyond the guidelines - new developments and future directions: CMV
  
  Atul Humar (CA)
- Panel discussion: challenging BK case, challenging CMV case
  
  Discussion Period (AU)

Pediatric general

8:00 AM – 9:00 AM Room C4.9 Abstract Session
Moderator: Bethany J. Foster (CA)
- Dysregulated succinate metabolism in M1 macrophages promotes hepatic stellate cell activation and graft fibrosis after pediatric liver transplantation
  
  Zhixin Zhang (CN)
- Protective anti-HBs thresholds and risk of De Novo hepatitis B after pediatric liver transplantation using anti-HBc–positive donor grafts
  
  Figen Ozcay (TR) · 413-2
  
  Details
- Pediatric organ donation after circulatory death in the United States
  
  Matthew Goldstein (US) · 413-3
  
  Details
- Long-term outcomes of pediatric donation after circulatory death (DCD) liver transplantation: preliminary results from an European liver transplant registry study
  
  Francesca Albanesi (IT) · 413-4
  
  Details
- Paediatric Lung Transplantation for Pulmonary Hypertension: Excellent Outcomes in a Nationally Centralised Program
  
  Miranda Paraskeva (AU) · 413-5
  
  Details
- Identifying an appropriate KDPI max value for paediatric renal recipients
  
  Fiona Hudson (AU) · 413-6
  
  Details
- Measles-Mumps-Rubella vaccination after paediatric heart transplantation
  
  Anne Dipchand (CA) · 413-7
  
  Details
- International Comparisons of Paediatric Organ Donation Systems: a Mixed-Methods Systematic Review of Policies, Practices, and Interventions Associated with Higher Consent Rates
  
  Leah McLaughlin (GB) · 413-8
  
  Details

HLA, antibodies, and alloimmune risk in transplantation: Kidney-focused insights with cross-organ relevance

8:00 AM – 9:00 AM Room C4.10 Abstract Session
Moderator: Anne Halpin (CA)
- Angiotensin II type I receptor antibodies are associated with retransplantation in liver allografts
  
  Jeyamani Ramachandran (AU) · 414-1
  
  Details
- Early twice-daily dosing of extended-release tacrolimus improves target trough attainment after kidney transplantation: A prospective randomized controlled study
  
  Yun Miao (CN) · 414-2
  
  Details
- 2026 Update of the Serologic Nomenclature for Factors of the HLA System; its impact in listing Unacceptable HLA antigens and DSA assessment
  
  Marcelo Fernandez Viña (US) · 414-3
  
  Details
- Impact of preformed donor specific antibodies on rejection, allograft survival and mortality in kidney transplant recipients: An Australian registry study
  
  Paayal Naidu (AU) · 414-4
  
  Details
- Evaluating the Impact of Shared Eplets on Cross-Reactivity in Single Antigen Bead Assays Using Customized HLA Bead Panels
  
  Daiki Iwami (JP) · 414-5
  
  Details
- Donor specific antibodies in paediatric liver allograft T cell mediated rejection
  
  Suzan Warner (AU) · 414-6
  
  Details
- Integrated HLA Epitope and PIRCHE-Based Modeling Improves Immunological Risk Stratification in Kidney Transplantation
  
  Ahmed Mostafa (CA) · 414-7
  
  Details
- Acute Rejection in Pediatric Kidney Transplantation: The Central Role of De Novo Donor-Specific Antibodies and Impact of Targeted Therapy on Graft Outcomes
  
  Alaa Alsaqqa (AE) · 414-8
  
  Details
- Molecular pathological diagnosis and clinical decision-making system based on mRNA expression profile and immunohischemistry in kidney transplantation
  
  Ping Lan (CN) · 414-9
  
  Details

Beyond static cold storage: Hypothermic machine perfusion in transplantation—from mechanisms to clinical impact

8:00 AM – 9:00 AM Room C4.11 Abstract Session
- A next-generation multicomponent perfusion solution targeting mitochondrial reverse electron transport and ferroptosis for hypothermic oxygenated machine perfusion of donor organs
  
  Boris Yaremin (RU) · 415-1
  
  Details
- Hypothermic oxygenated perfusion improves recipient survival in a rodent model of allogeneic intestinal transplantation
  
  Koki Takase (US) · 415-2
  
  Details
- First experience with hypothermic oxygenated perfusion of human uteri: Feasibility and metabolic characterization
  
  Keyue Sun (US) · 415-3
  
  Details
- Real-World Use of Hypothermic Machine Perfusion: Trends and Impact on Short-Term Kidney Allograft Outcomes
  
  Alexander Cortez (US) · 415-4
  
  Details
- Comparative Efficacy of Continuous Hypothermic Machine Perfusion, Hybrid Machine Perfusion with Static Cold Storage, and Static Cold Storage Alone on Kidney Transplant Outcomes: A Single-Center Cohort Study
  
  Valeria Ripa (US) · 415-5
  
  Details
- Beyond static cold storage: active hypothermic lung preservation at 10°C using perfusion and CPAP in a porcine model
  
  Irene bello (ES) · 415-6
  
  Details
- Transplanting green kidneys in the era of machine perfusion
  
  Greta Gurry (AU) · 415-7
  
  Details
- Comparative Analysis of Short-Term Outcomes of Hypothermic Oxygenated Machine Perfusion Versus Static Cold Storage in Deceased Donor Liver Transplantation: A Single-Centre Experience
  
  Kandarpa Akhil (IN) · 415-8
  
  Details
- Hypothermic oxygenated machine perfusion for partial grafts in a porcine model simulating living donor liver transplantation
  
  Ayaka Satoh (JP) · 415-9
  
  Details

Abstract and Concurrent Sessions

ABO-incompatible kidney transplantation and antibody mediated rejection

9:15 AM – 10:15 AM Room Cockle Bay 1 Abstract Session
- ABO-compatible kidney allocation with ABO-adjusted CPRA
  
  Michal Mankowski (US) · 420-1
  
  Details
- ABO-incompatible kidney transplantation without desensitization - A German multicenter cohort study
  
  Martina Koch (DE) · 420-2
  
  Details
- Luminex mixed bead and single antigen bead assays have high positive percentage agreement for HLA-A, B and DR, with less agreement identified at HLA-DQ
  
  Petrina Guthrie (AU) · 420-3
  
  Details
- Integrating Serological CREG and Molecular Eplet Analysis Enhances Characterization of Alloreactivity in Sensitized Renal Transplant Recipients: A Single-Centre Study
  
  Chippy C S (IN) · 420-4
  
  Details
- Clinical outcomes and prognostic factors of ABO-incompatible kidney transplantation: A single-center retrospective study using propensity score matching
  
  Myung Yup Hyun (KR) · 420-5
  
  Details
- Combination Strategies with Daratumumab to Mitigate Rebound in Kidney Transplant ABMR: A Real-World Study
  
  Huanxi Zhang (CN) · 420-6
  
  Details
- Clinical Practice of Complement C5 Monoclonal Antibody in ABO-Incompatible Living Related Donor Kidney Transplantation
  
  Puxun Tian (CN) · 420-7
  
  Details

Ischaemia reperfusion injury

9:15 AM – 10:15 AM Room Cockle Bay 2 Abstract Session
Moderator: Stephen Alexander (AU)
- THBS1 Acts as an Intracellular "Brake" to Orchestrate Immune Remodeling and Mitigate Post-transplantation Liver Injury
  
  Bowen Wu (CN) · 421-1
  
  Details
- Mitochondrial Priming and Metabolic Unloading Synergistically Restore Energetics in DCD Hearts: A Combined Cardioplegia-Phase Ischemic Preconditioning and Machine Perfusion-Phase Dialysis Strategy
  
  Priyanka Prem (IN) · 421-2
  
  Details
- RhoA/ROCK2/MYL9 signaling pathway mediates ischemia-reperfusion injury and fibrosis after liver transplantation
  
  Zhixin Zhang (CN) · 421-3
  
  Details
- IL-27Rα Deficiency Attenuates Renal Ischemia-Reperfusion Injury via Regulating Macrophage Polarization and Inhibiting Endoplasmic Reticulum Stress
  
  Yingqi Zeng (CN) · 421-4
  
  Details
- PGE2 induces hypermethylation in MDSCs, thereby protecting against ischaemia-reperfusion injury in kidney transplantation
  
  Xiaoyan Huang (CN) · 421-5
  
  Details
- Translation study to document application of treprostinil for minimizing ischemia-reperfusion injury in donation after circulatory death livers using normothermic machine perfusion
  
  Shambhavi Parab (US) · 421-6
  
  Details
- Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice
  
  Kosuke Tanaka (JP) · 421-7
  
  Details
- Time resolved proteomic signatures of ischemia–reperfusion injury in a porcine donation after circulatory death simulated liver transplant model using ex vivo machine perfusion
  
  Mun Chae Choi (KR) · 421-8
  
  Details

Economics, environment and patient experience in kidney transplantation

9:15 AM – 10:15 AM Room C3.3 Abstract Session
- Impact of different eplet matching strategies on the feasibility and equity of eplet based kidney allocation
  
  James Lan (CA) · 422-1
  
  Details
- Environmental performance of kidney replacement therapies: A comparative lifecycle assessment
  
  Christopher Nguan (CA) · 422-2
  
  Details
- The UAE Journey for Organ Transplantation: Evolution and Clinical Outcomes of a National and Pediatric Program (2017–2026)
  
  Abdalazeez Alghraizat (AE) · 422-3
  
  Details
- Advancing deceased organ donation and transplantation in Dubai: A three-year analysis of system growth, clinical outcomes, and regional collaboration (2023–2025)
  
  HICHAM Aboualloul (AE) · 422-4
  
  Details
- A Natural Experiment in Allocation: Outcomes of Mate Kidneys in Simultaneous Liver–Kidney Versus Kidney-Alone Transplantation
  
  Oscar Garcia Valencia (US) · 422-5
  
  Details
- Out-of-pocket expenditure and financial implications of renal transplant in children at a not-for-profit tertiary care hospital in a low-middle-income country
  
  Indira Agarwal (IN) · 422-6
  
  Details
- Patient perspectives on loneliness and social isolation in people receiving kidney replacement therapy including kidney transplant recipients: An interview study.
  
  Amanda Sluiter (AU) · 422-7
  
  Details
- Survival of dialysis patients who declined kidney transplantation.
  
  Liliana Bisigniano (AR) · 422-8
  
  Details
- Survival After Kidney Transplantation Versus Dialysis in Waitlisted Patients with Diabetic Kidney Disease : A Target Trial Emulation Study
  
  Jiayue Wang (AU) · 422-9
  
  Details

Immunoregulation in transplantation 2

9:15 AM – 10:15 AM Room C3.4-C3.5 Abstract Session
- NR4A1⁺ Immunoregulatory Macrophages Protect Renal Allografts from Chronic Rejection by Anchoring and Taming CD8⁺ Tissue-Resident Memory T Cells via a Dual-Signal Axis
  
  Chao Yang (CN) · 423-1
  
  Details
- Ex vivo Genetic Silencing of Donor MHC via Normothermic Machine Perfusion Achieves Long-term Renal Allograft Survival
  
  Tong Chen (CN) · 423-2
  
  Details
- IL4I1-I3P-AhR Axis-Mediated Tryptophan Metabolic Hijacking Orchestrates an mregDC-Treg Spatial Niche to Promote Allograft Tolerance
  
  Zetao Ding (CN) · 423-3
  
  Details
- CX3CR1+CD4+ cytotoxic T Cells target cholangiocyte self-antigens to drive autoimmunity in biliary atresia
  
  Wanglong Xiao (CN) · 423-4
  
  Details
- Spatial dynamics of the T cell response to solid organ transplantation in mice
  
  Amy Prosser (AU) · 423-5
  
  Details
- Gut microbiota causally regulates allograft rejection through suppression of T helper 17 cell responses
  
  Yanzhuo Liu (CN) · 423-6
  
  Details
- Prospective analysis of lymphocytic immunophenotypical alterations in liver transplant recipients
  
  Georgios Lioulios (GR) · 423-7
  
  Details
- Interleukin-27Rα deficiency promotes acute kidney injury through enhancing M1 macrophages polarization via the JAK1/STAT1 pathway
  
  Chen Feng (CN) · 423-8
  
  Details

Advances in organ preservation, perfusion, and peri-transplant monitoring across liver, kidney, and pancreas transplantation

9:15 AM – 10:15 AM Room C3.6 Abstract Session
Moderator: Oscar Garcia Valencia (US)
- Fingerprint in the cold: Perfusate profiling of extended criteria donor livers during hypothermic oxygenated perfusion using Raman spectroscopy
  
  Meryl Copray (NL) · 424-1
  
  Details
- Sentinel skin flaps for monitoring of pancreas transplants
  
  Helen Stark (GB) · 424-2
  
  Details
- A four-component reconstruction planning in liver transplantation with 4d flow MRI validation
  
  Bakhtiyar Kazymov (RU) · 424-3
  
  Details
- Interim report on NEWHOPE: a first-in-human study on hypothermic machine perfusion with Omnisol preservation solution of deceased donor kidneys prior to transplantation
  
  Liselotte Jeletich (NL) · 424-4
  
  Details
- Frequency and financial impact of DCD liver procurement dry runs in the normothermic machine perfusion era
  
  Alexander Cortez (US) · 424-5
  
  Details
- Ischemia-Free Liver Transplantation Reduces the Incidence of New-Onset Diabetes After Transplantation
  
  Ruilin Cai (CN) · 424-6
  
  Details
- Hypothermic and normothermic combined machine perfusion enables safe transplantation of moderate-to-severe steatotic liver allografts
  
  Mikhail Boldyrev (RU) · 424-8
  
  Details
- Ischemia-free liver transplantation: 7-year experience from a single-centre cohort in China
  
  Meng Qingze (CN) · 424-9
  
  Details

From allorecognition to allocation: Moving toward more individualized kidney transplant matching

9:15 AM – 10:15 AM Room C4.1 Concurrent
Moderator: Rhonda Holdsworth (AU)
- Importance of HLA beyond the A/B/DR
  
  Anat Tambur (US)
- Beyond HLA: Expanding the immunologic landscape
  
  Toby Coates (AU)
- Precision risk stratification
  
  Wai Lim (AU)

Advancing equity and innovation in transplantation: From donor assessment to allocation and novel therapies

9:15 AM – 10:15 AM Room C4.2 Abstract Session
- Timing and allocation trade-offs in liver transplantation for colorectal liver metastases: A decision-analytic study
  
  Quirino Lai (IT) · 426-1
  
  Details
- Toxoplasma gondii screening and seroprevalence in Australasian deceased organ donors
  
  Madeleine Bangham (AU) · 426-2
  
  Details
- Simultaneous transjugular intrahepatic portosystemic shunt and intraportal autologous mesenchymal stem cell infusion via a single access route in cirrhotic patients: A first-in-human proof-of-concept study
  
  Sergey Astapovich (RU) · 426-3
  
  Details
- Transplantation inequities among Hispanic and Latino Americans in the United States: A swim review with quantitative narrative synthesis
  
  Giuseppe Orlando (US) · 426-4
  
  Details
- Factors contributing to gender disparity in access to kidney replacement therapy in pediatric population in various regions of India: prospective observational multicenter study
  
  Kinnari Vala (IN) · 426-5
  
  Details
- Preoperative CT volumetry: Diagnostic accuracy and correlation with intraoperative graft weight in living liver donors
  
  Syed Jawad Shah (PK) · 426-6
  
  Details
- Mechanistic study of PI3K/mTOR signaling pathway combined with immune checkpoint blockade on immune balance in hepatocellular carcinoma and heart transplantation
  
  Xiaolong Miao (CN) · 426-7
  
  Details

Post-transplant complications, risk prediction & outcomes

9:15 AM – 10:15 AM Room C4.5 Abstract Session
Moderator: Jiri Fronek (CZ)
- Rate, Risk Factors and Outcomes of Early Hepatic Artery and Portal Vein Thrombosis After Pediatric Liver Transplantation: A 20-Year Review of a Large North American Center
  
  Blayne Amir Sayed (CA) · 428-1
  
  Details
- Donor liver-derived FGF21 protects against tacrolimus-induced post-transplant diabetes mellitus through regulation of the CerS4/C18:0 ceramide lipotoxicity axis
  
  Xinyu Yang (CN) · 428-2
  
  Details
- Incidence and Outcomes of Malignancy Following Adult Intestinal Transplantation: A National Cohort Study
  
  Naeem Abdul Ghafoor (GB) · 428-3
  
  Details
- Osteonecrosis After Liver Transplantation: The Role of Pre-transplant Disease Burden Beyond Corticosteroid Exposure
  
  Eun Sung Jeong (KR) · 428-4
  
  Details
- Impact of Radiation Therapy on Biliary Complications in Liver Transplantation Recipients with Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
  
  Minha Choi (KR) · 428-5
  
  Details
- Independent Risk Factors and Predictors of Maintenance Duration for Tracheostomy in Liver Transplant Recipients: A Comprehensive Multivariable Analysis
  
  Minha Choi (KR) · 428-6
  
  Details
- Risk Stratification Tool for Primary Nonfunction After Pediatric Liver Transplantation: A Novel Model to Guide Urgent Retransplantation
  
  Shuangqing Han (CN) · 428-7
  
  Details
- Different knots, similar outcomes: Surgical technique does not influence anastomotic stricture risk in duct-to-duct transplants!
  
  Samith Alwis (AU) · 428-8
  
  Details

Immunosuppression in liver and kidney transplantation

9:15 AM – 10:15 AM Room C4.6 Abstract Session
Moderators: Jennifer Garcia (US), Roslyn B. Mannon (US)
- CD40L-Target Nanoparticles Co-Delivering Sirolimus and CD28 siRNA for the Suppression of Allogeneic Liver Transplantation Rejection
  
  Xiandong Zeng (CN) · 429-1
  
  Details
- Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor - Results of the French ISKIA Registry
  
  Lionel Couzi (FR) · 429-2
  
  Details
- Encore presentation: The ConfIdeS study: Imlifidase desensitization results in timelier transplant with superior 1-year eGFR among highly sensitized patients compared to control
  
  Robert A. Montgomery (US) · 429-3
  
  Details
- Induction immunosuppression strategy and long-term graft and patient survival in contemporary adult liver transplantation: A United States allocation-era reassessment
  
  Isabella Faria (US) · 429-4
  
  Details
- VISTA positive macrophages define an immature tertiary lymphoid niche in renal allograft tolerance
  
  Rui Shi (CN) · 429-6
  
  Details
- Tacrolimus Exposure Variability and Viral Infection Risk after Kidney Transplantation: A Stratified Analysis Using TTR and CV
  
  Hyung Sub Park (KR) · 429-7
  
  Details

Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring

9:15 AM – 10:15 AM Room C4.7 Abstract Session
Moderators: Kavitha Muthiah (AU), Lori J. West (CA)
- Heart transplantation during the War: Breaking barriers and exploring new frontiers
  
  Borys Todurov (UA) · 430-1
  
  Details
- Cardiovascular Magnetic Resonance-Guided Rejection Surveillance in Cardiac Transplantation: Five-year Safety Outcomes
  
  Yiling Situ (AU) · 430-2
  
  Details
- The role of blood plasma cytokines in the diagnosis of rejection long-term after heart transplantation
  
  Maria Simonenko (RU) · 430-3
  
  Details
- Progression of cardiac allograft vasculopathy in heart recipients with donor-transmitted coronary atherosclerosis
  
  Stepan Sakhovsky (RU) · 430-4
  
  Details
- Evaluation of the coronary arteries of a heart transplant using optical coherence tomography
  
  Stepan Sakhovsky (RU) · 430-5
  
  Details
- HLA mismatch burden and De Novo malignancy after heart transplantation: A single-center Korean cohort study
  
  Darae Kim (KR) · 430-6
  
  Details
- CXCR6-regulated local CD8⁺ T-cell exhaustion enables the uncoupling of acute cellular rejection from anti-infective immunity in heart transplantation
  
  Yu Zhang (CN) · 430-7
  
  Details
- Genetic testing yield in heart transplant recipients with an undifferentiated cardiomyopathy – a single centre experience in Western Australia
  
  Ellen McGuckin (AU) · 430-8
  
  Details
- Long Term Survival and Graft Related Outcomes After Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy in Contemporary Australian Heart Transplant Recipients
  
  Ajay Dharan (AU) · 430-9
  
  Details

Clinical outcomes, perioperative management, and organ utilization in transplantation

9:15 AM – 10:15 AM Room C4.9 Abstract Session
Moderator: Henry Pleass (AU)
- Optimal timing of double J stent removal after kidney transplantation: a multicenter KQIPS cohort study
  
  Seung Jae Jason Kim (KR) · 432-1
  
  Details
- Towards Outpatient Kidney Transplant: A Comparative Analysis of the AWAKE trial versus Standard Kidney Transplantation
  
  Vinayak Rohan (US) · 432-2
  
  Details
- The effect of intraoperative thermal kidney insulation on current kidney transplantation surgical practices: a feasibility study.
  
  Amy Hort (AU) · 432-3
  
  Details
- ‘Kidney-First’ Retrieval: A value enhancing approach to organ retrieval
  
  Akshay Kriplani (IN) · 432-4
  
  Details
- Transplant renal artery stenosis: Validation for a new patho-anatomic classification with systematic review of the literature
  
  Animesh Singla (AU) · 432-5
  
  Details
- Transplant renal artery stenosis: Proposal for a new patho-anatomic classification using intra-vascular ultrasound.
  
  Animesh Singla (AU) · 432-6
  
  Details
- Lessons learned transplanting single pediatric kidneys into adult recipients - single center experience
  
  Alex Zendel (US) · 432-7
  
  Details
- Towards extended preservation of human livers during long-term normothermic machine perfusion: The role of bile acids
  
  Xuwenxuan Lucia Xie (AU) · 432-8
  
  Details
- Donor In-Situ Ischemia Time: A Novel Modifiable Risk Factor for Early Graft Dysfunction in Kidney Transplantation
  
  Paul Robertson (AU) · 432-9
  
  Details
- Comparative Assessment of Early Graft Injury Using Zero-Time Biopsy After Robotic Versus Open Kidney Transplantation
  
  MOHAMMAD SHERWANI (IN) · 432-10
  
  Details
- To preserve or to ligate? Surgical decision-making in multiple renal artery kidney transplantation: A meta-analysis
  
  Firtantyo Adi Syahputra (ID) · 432-11
  
  Details

Transplantation beyond traditional publications

9:15 AM – 10:15 AM Room C4.10 Concurrent
Moderators: Stefan Tullius (US), Macey L. Levan (US)
- Special features: A reality check on opportunities and challenges
  
  Fadi Issa (GB)
- Social media: Are we reaching our audience and readership worldwide
  
  Jasper Iske (DE)
- Editorial fellowships: A great opportunity to be involved
  
  Melanie Wyld (AU)
- Topic highlights – Article series
  
  Camille N. Kotton (US)
- Panel discussion
  
  Discussion Period (AU)
- Panelist
  
  Khushboo Saxena (IN)

Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement

9:15 AM – 10:15 AM Room C4.11 Abstract Session
- Single-cell spatial mapping of immune microenvironments across the spectrum of skin rejection in vascularized composite allotransplantation
  
  Sarah Short (GB) · 434-1
  
  Details
- Toward Clinical Translation of NICHE: A Directly Vascularized Subcutaneous Platform with Local Immunomodulator Delivery for Pancreatic Islet Transplantation in Type 1 Diabetes
  
  Alessandro Grattoni (US) · 434-2
  
  Details
- Application and Mechanism of Bionic Leaf Vein Chip in the Construction of Bioartificial Kidney
  
  Zejiaxin Niu (CN) · 434-3
  
  Details
- Functional Restoration of Apico-basal Polarity and Vascularization in Liver Organoids: A Highly Physiological Unit for Organ Replacement
  
  Mengyu Gao (CN) · 434-4
  
  Details
- A Human Vascularized Liver Tissueoid-on-Chip Platform for Dissecting T cell- and Antibody-Mediated Allograft Rejection
  
  Vadim Jucaud (US) · 434-5
  
  Details
- Modeling Antibody-Mediated Endothelial Activation in a Human Vascularized Heart Wall Tissueoid-on-Chip
  
  Vadim Jucaud (US) · 434-6
  
  Details

Coffee Break / Last chance to visit Exhibit Area

Coffee Break

10:15 AM – 10:45 AM Room Hall 1-2 Coffee Break

No lectures listed yet.

Plenary and Concurrent Sessions / TTS Business Meeting

Plenary Session 3

10:45 AM – 12:00 PM Room Darling Harbour Plenary Session
- Adverse pregnancy outcomes driven by tacrolimus blockade of IL-15-dependent differentiation of tissue resident natural killer cells
  
  Brittney Knott (US) · 440-1
  
  Details
- Immune response and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (adjuvanted RSVPreF3) in immunocompromised (IC) adults with lung or kidney transplant compared to non-IC adults up to 12 months post-vaccination
  
  Steve Chadban (AU) · 440-2
  
  Details
- Towards transplantable organs: Organoids as a future source for kidney transplantation
  
  Ton J. Rabelink (NL)
- ABO beyond landsteiner: The next chapter in transplant histocompatibility
  
  Lori J. West (CA)

Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development

10:45 AM – 12:00 PM Room C4.9 Concurrent
Moderators: Pablo Uva (AR), Toby Coates (AU)
- Current status of pancreas transplantation: Activity and outcomes around the world
  
  Angelika C. Gruessner (US)
- Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes
  
  Joana Ferrer (ES)
- Future of pancreas transplantation in the landscape of emerging therapies
  
  Raja Kandaswamy (US)

TTS Business Meeting

12:00 PM – 12:30 PM Room Darling Harbour Plenary Session

No lectures listed yet.

Lunch Break / Industry Symposia / Lunch with Experts & Mentors

Industry Symposium

12:45 PM – 1:45 PM Room Parkside 1&2 Industry Symposium

No lectures listed yet.

Lunch and Learn Roundtable

12:45 PM – 1:30 PM Room The Gallery Experts/Mentors
- Combined liver–kidney transplantation
  
  Gomathy Narasimhan (IN)
- Designing and strengthening organ donation systems
  
  Marti Manyalich Vidal (ES)
- Genetic factors influencing transplant outcomes
  
  Stephen Alexander (AU)
- Clinical Trials in Kidney Transplantation
  
  Steve Chadban (AU)
- From HLA typing to epitope matching
  
  Lucy Sullivan (AU)
- Encouraging physical activity in transplant recipients with limited endurance or physical limitations
  
  Liz Schick (CH)
- Roundtable Mentor
  
  Roslyn B. Mannon (US)
- Roundtable Mentor
  
  Germaine Wong (AU)
- Roundtable Mentor
  
  Kate Wyburn (AU)
- Roundtable Mentor
  
  Medhat Askar (QA)
- Roundtable Mentor
  
  Macey L. Levan (US)
- Roundtable Mentor
  
  Henry Pleass (AU)
- TBD related to Uterus Transplant (ethics or donor/recipient selection or pregnancy challenge, etc)
  
  Mats Brännström (SE)
- Multi-Organ transplantation in children
  
  Tomoaki Kato (US)

SOTA, Thematic and Concurrent Sessions

Clinical Xenotransplantation has Arrived!

1:45 PM – 3:15 PM Room Cockle Bay 1 SOTA/Thematic Session
Moderators: Richard N. Pierson (US), Robert A. Montgomery (US)
- Understanding optimal genetic modification
  
  Peter Cowan (AU)
- Experience and immunosuppression for clinical xenotransplantation
  
  Muhammad Mohiuddin (US)
- Molecular analysis in clinical xenotransplantation
  
  Carmen Lefaucheur (FR)
- Clinical xenotransplantation: A new era through the eyes of patients and families
  
  Macey L. Levan (US)

Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances

1:45 PM – 3:15 PM Room Cockle Bay 2 SOTA/Thematic Session
Moderators: Kwang Woong Lee (KR), Henry Pleass (AU)
- Shared framework for living donor evaluation: medical, psychosocial, and ethical core
  
  Krista Lentine (US)
- Surgical challenges and functional outcomes in living kidney donation
  
  Mireia Musquera (ES)
- Surgical challenges and functional outcomes in living liver donation
  
  DongJin Joo (KR)
- Predictive models and global registry insights to enhance donor safety
  
  Allan Massie (US)

Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment

1:45 PM – 3:15 PM Room C3.3 SOTA/Thematic Session
Moderator: Jen Li (AU)
- Is there still a role for anti IL-6R in ABMR treatment?
  
  Roslyn B. Mannon (US)
- Is anti-CD38 the most promising agent for ABMR?
  
  Katharina Mayer (AT)
- What does monitoring AUC add compared to C-trough only?
  
  Teun van Gelder (NL)
- Model Informed precision dosing
  
  Anders Asberg (NO)

Pediatric cholestatic liver disease around the world

1:45 PM – 3:15 PM Room C3.4-C3.5 Concurrent
Moderators: Gabriel E. Gondolesi (US), Manuel Rodriguez-Davalos (US)
- Biliary atresia - whats happening in Latin America. Access to KPE and transplantation
  
  Monserrat Arreola Gutierrez (MX)
- Alagille syndrome - past, present and future
  
  Susan Mei-Ling Siew (AU)
- Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy
  
  Mohamed Rela (IN)
- Primary sclerosing cholangiotis in children and adolescent
  
  Michael Stormon (AU)

Diversity, Equity, and Inclusion in Gender and Transplantation

1:45 PM – 3:15 PM Room C3.6 SOTA/Thematic Session
Moderators: Maria Gomez (AE), Victorine Bandolo Nzana (CM)
- Regional and gender disparities in abstracts presented at international transplant congress
  
  Maggie Kam Man Ma (HK)
- Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantation
  
  Nicole Jane Scholes-Robertson (AU)
- Redefining equity: Women, access, and outcomes in liver transplantation
  
  Gomathy Narasimhan (IN)
- Designing gender-responsive transplant policies: Lessons from south and southeast Asia
  
  Yeong Hoon Kim (KR)

Evolving Ethics and Emerging Trends in Transplantation

1:45 PM – 3:15 PM Room C4.1 SOTA/Thematic Session
Moderators: David Thomson (ZA), Aviva Goldberg (CA)
- Rating ourselves on the ethics of NRP - How are we doing?
  
  Anji Wall (US)
- Social media use in transplantation
  
  Shaifali Sandal (CA)
- Pediatric prioritization
  
  Thozama Siyotula (ZA)
- Retransplantation after nonadherence (adult & children)
  
  Aaron Wightman (US)

Innovations in skin cancer in transplantation

1:45 PM – 3:15 PM Room C4.5 SOTA/Thematic Session
Moderators: Angela Webster (AU), Brenda Maria Rosales (AU)
- Skin cancer risk prediction and communication
  
  Anne Cust (AU)
- Evaluation of benefits and harms of melanoma screening in chronic disease
  
  Katy Bell (AU)
- Complex surgical oncology
  
  Alexander Varey (AU)
- Novel developments in keratinocyte cancer treatments in Australia
  
  Kiarash Khosrotehrani (AU)
- Panel Discussion
  
  Discussion Period (AU)

Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation

1:45 PM – 3:15 PM Room C4.6 SOTA/Thematic Session
Moderators: Miranda Paraskeva (AU), Pablo Sanchez (US)
- Debate 1: Pro normothermic regional perfusion
  
  Ashish S. Shah (US)
- Debate 1: Pro ex vivo machine perfusion
  
  Peter MacDonald (AU)
- Debate 2: Pro ex vivo perfusion
  
  Sandra Lindstedt Ingemansson (SE)
- Debate 2: Pro immediate transplant
  
  Gregory I. Snell (AU)
- Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recovery
  
  Irene Bello Rodriguez (ES)
- Panel Discussion
  
  Discussion Period (AU)

State of VCA- Present and Future

1:45 PM – 3:15 PM Room C4.7 SOTA/Thematic Session
Moderators: Patrik Lassus (FI), Hatem Amer (US)
- Overview of VCA transplants
  
  Hatem Amer (US)
- VCA becoming part of universal health care
  
  David Leonard (GB)
- Is VCA reconstructive surgery or transplantation
  
  Linda C. Cendales (US)
- Challenges and opportunities for VCA in the global south
  
  Subramania Iyer (IN)
- Standardizing outcomes in VCA: Are we ready for a SONG or for COVER
  
  Allison Jaure (AU)

Next-Generation Transplantation: Regenerative Medicine Breakthroughs

1:45 PM – 3:15 PM Room C4.8 SOTA/Thematic Session
Moderator: Giuseppe Orlando (US)
- The bioartificial kidney: Lessons learned and the road ahead
  
  William Fissell (CA)
- Organoids, organs-on-a-chip, and the path to organ manufacturing
  
  Sean Vincent Murphy (US)
- Artificial heart: A life-saving bridge to transplant
  
  Francisco Arabia (US)

Evolving strategies in intestinal and multivisceral transplantation

1:45 PM – 3:15 PM Room C4.9 SOTA/Thematic Session
Moderators: Helen Evans (NZ), Rajith Amaratunga (AU)
- Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist
  
  Yaron Avitzur (CA)
- Novel immunosuppression in intestine transplantation
  
  Jennifer Garcia (US)
- Pros and cons of protocol biopsy and stoma
  
  Jonathan Hind (AU)

Organ donation following MAID (VAD/euthanasia)

1:45 PM – 3:15 PM Room C4.11 Concurrent
Moderator: Helen Opdam (AU)
- Panelist representing Canada
  
  Matthew Weiss (CA)
- Panelist representing Australia
  
  Wade Stedman (AU)

Closing Plenary

Closing Plenary

3:20 PM – 4:30 PM Room Parkside 1&2 Plenary Session
Introducer: Nadey Hakim (GB)
- Gene and cell therapy in transplantation
  
  Maria Grazia Roncarolo (US)
- From donor to recipient: Microbiome signatures as predictors of post-transplant complications
  
  Olivia Smibert (AU)